Combined use of CEMIP and CA 19-9 enhances diagnostic accuracy for pancreatic cancer

Carbohydrate antigen (CA) 19-9 is the only diagnostic marker used in pancreatic cancer despite its limitations. Here, we aimed to identify the diagnostic role of CEMIP (also called KIAA1199) combined with CA 19-9 in patients with pancreatic cancer. A retrospective analysis of prospectively collected...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hee Seung, Jang, Chan Young, Kim, Sun A, Park, Soo Been, Jung, Dawoon E., Kim, Bo Ok, Kim, Ha Yan, Chung, Moon Jae, Park, Jeong Youp, Bang, Seungmin, Park, Seung Woo, Song, Si Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821821/
https://www.ncbi.nlm.nih.gov/pubmed/29467409
http://dx.doi.org/10.1038/s41598-018-21823-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821821/
https://www.ncbi.nlm.nih.gov/pubmed/29467409
http://dx.doi.org/10.1038/s41598-018-21823-x

Ejemplares similares